Bioactive compounds from the sea

Chris M. Ireland, Brent R. Copp, Mark P. Foster, Leonard A. McDonald, Derek C Radisky, J. Christopher Swersey

Research output: Chapter in Book/Report/Conference proceedingChapter

13 Citations (Scopus)

Abstract

This chapter - while not a complete review of bioactive marine natural products (see Faulkner, 1984) - will pay particular attention to those metabolites which have been or are being developed as pharmaceuticals, and to those compounds which have significantly aided the understanding of cellular processes at the biochemical level. A distinction between these two categories is difficult to make, as what usually distinguishes an effective drug from a molecular probe is the degree of toxicity associated with said compound.

Original languageEnglish (US)
Title of host publicationMarine and Freshwater Products Handbook
PublisherCRC Press
Pages641-661
Number of pages21
ISBN (Electronic)9781482293975
ISBN (Print)9781566768894
StatePublished - Jan 1 2000
Externally publishedYes

Fingerprint

Metabolites
Oceans and Seas
Drug products
Toxicity
Biochemical Phenomena
Molecular Probes
drugs
Biological Products
Pharmaceutical Preparations
metabolites
toxicity
bioactive compounds

ASJC Scopus subject areas

  • Engineering(all)
  • Agricultural and Biological Sciences(all)

Cite this

Ireland, C. M., Copp, B. R., Foster, M. P., McDonald, L. A., Radisky, D. C., & Christopher Swersey, J. (2000). Bioactive compounds from the sea. In Marine and Freshwater Products Handbook (pp. 641-661). CRC Press.

Bioactive compounds from the sea. / Ireland, Chris M.; Copp, Brent R.; Foster, Mark P.; McDonald, Leonard A.; Radisky, Derek C; Christopher Swersey, J.

Marine and Freshwater Products Handbook. CRC Press, 2000. p. 641-661.

Research output: Chapter in Book/Report/Conference proceedingChapter

Ireland, CM, Copp, BR, Foster, MP, McDonald, LA, Radisky, DC & Christopher Swersey, J 2000, Bioactive compounds from the sea. in Marine and Freshwater Products Handbook. CRC Press, pp. 641-661.
Ireland CM, Copp BR, Foster MP, McDonald LA, Radisky DC, Christopher Swersey J. Bioactive compounds from the sea. In Marine and Freshwater Products Handbook. CRC Press. 2000. p. 641-661
Ireland, Chris M. ; Copp, Brent R. ; Foster, Mark P. ; McDonald, Leonard A. ; Radisky, Derek C ; Christopher Swersey, J. / Bioactive compounds from the sea. Marine and Freshwater Products Handbook. CRC Press, 2000. pp. 641-661
@inbook{6b69e2cad1aa43b1872685ef4d410125,
title = "Bioactive compounds from the sea",
abstract = "This chapter - while not a complete review of bioactive marine natural products (see Faulkner, 1984) - will pay particular attention to those metabolites which have been or are being developed as pharmaceuticals, and to those compounds which have significantly aided the understanding of cellular processes at the biochemical level. A distinction between these two categories is difficult to make, as what usually distinguishes an effective drug from a molecular probe is the degree of toxicity associated with said compound.",
author = "Ireland, {Chris M.} and Copp, {Brent R.} and Foster, {Mark P.} and McDonald, {Leonard A.} and Radisky, {Derek C} and {Christopher Swersey}, J.",
year = "2000",
month = "1",
day = "1",
language = "English (US)",
isbn = "9781566768894",
pages = "641--661",
booktitle = "Marine and Freshwater Products Handbook",
publisher = "CRC Press",

}

TY - CHAP

T1 - Bioactive compounds from the sea

AU - Ireland, Chris M.

AU - Copp, Brent R.

AU - Foster, Mark P.

AU - McDonald, Leonard A.

AU - Radisky, Derek C

AU - Christopher Swersey, J.

PY - 2000/1/1

Y1 - 2000/1/1

N2 - This chapter - while not a complete review of bioactive marine natural products (see Faulkner, 1984) - will pay particular attention to those metabolites which have been or are being developed as pharmaceuticals, and to those compounds which have significantly aided the understanding of cellular processes at the biochemical level. A distinction between these two categories is difficult to make, as what usually distinguishes an effective drug from a molecular probe is the degree of toxicity associated with said compound.

AB - This chapter - while not a complete review of bioactive marine natural products (see Faulkner, 1984) - will pay particular attention to those metabolites which have been or are being developed as pharmaceuticals, and to those compounds which have significantly aided the understanding of cellular processes at the biochemical level. A distinction between these two categories is difficult to make, as what usually distinguishes an effective drug from a molecular probe is the degree of toxicity associated with said compound.

UR - http://www.scopus.com/inward/record.url?scp=34547519268&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547519268&partnerID=8YFLogxK

M3 - Chapter

AN - SCOPUS:34547519268

SN - 9781566768894

SP - 641

EP - 661

BT - Marine and Freshwater Products Handbook

PB - CRC Press

ER -